(Q44999397)

8 December 2017

Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy (English)

1 reference

8 December 2017

Pseudomonas aeruginosa

0 references

0 references

1 reference

Lee NG

1

1 reference

8 December 2017

Jung SB

2

1 reference

8 December 2017

Ahn BY

3

1 reference

8 December 2017

Kim YH

4

1 reference

8 December 2017

Kim JJ

5

1 reference

8 December 2017

Kim DK

6

1 reference

8 December 2017

Kim IS

7

1 reference

8 December 2017

Yoon SM

8

1 reference

8 December 2017

Nam SW

9

1 reference

8 December 2017

Kim HS

10

1 reference

8 December 2017

Park WJ

11

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

8 December 2017

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

8 December 2017

18

1 reference

8 December 2017

18

1 reference

8 December 2017

1952-1961

1 reference

Opportunistic infections in severely burned patients

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Outbreak of infection in a burns unit due to Pseudomonas aeruginosa originating from contaminated tubing used for irrigation of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Nosocomial infections in an oncology intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Intrinsic antibiotic resistance of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Controlled trials of a polyvalent pseudomonas vaccine in burns

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Aerobic, anaerobic and fungal burn wound infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Changes in immunoglobulin levels in severely burned patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

A Physiological Basis for the Development of Opportunistic Infections in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Protection of mice against P. aeruginosa infections by large-scale affinity-purified human IgG specific to P. aeruginosa outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Opsonic activity of sera and blister fluid from severely burned patients evaluated by a chemiluminescence method

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Lymphoid subpopulation changes after thermal injury and thermal injury with infection in an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Postburn constitutional changes in T-cell reactivity occur in CD8+ rather than in CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Changes in memory and naive CD4+ lymphocytes in lymph nodes and spleen after thermal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Factors in normal human serum that promote bacterial phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

Outer Membrane Proteins of Pseudomonas aeruginosa Serotype Strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900479-X

7 January 2021

10.1016/S0264-410X(99)00479-X

Identifiers

DOI

1 reference

release_vkd3htkotbb6lp6uimj4vci2f4

8 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vkd3htkotbb6lp6uimj4vci2f4

24 November 2022

mapped directly with Wikidata item

1 reference